Sun Pharma, officially known as Sun Pharmaceutical Industries Limited, was founded in 1983 by Dilip Shanghvi. The company is headquartered in India’s financial capital Mumbai, Maharashtra. Active Pharmaceuticals Ingredients (APIs) and formulations are known to be Sun Pharma’s specialised areas. It targets a wide spectrum of chronic and acute treatments. Its therapeutic segments of over 3000 high quality molecules include psychiatry, anti-infectives, neurology, cardiology, orthopaedic, diabetology, gastroenterology, ophthalmology, nephrology, urology, dermatology, gynaecology, respiratory, oncology, dental and nutritionals. On 15 June 2015, Sun Pharma was India’s largest pharmaceutical company with the market capitalisation valued at Rs. 2,01,706.41 crore.
Headquartered in Mumbai, Lupin Limited is a multinational pharmaceutical company. An associate professor at BITS-Pilani in Rajasthan, Dr. Desh Bandhu Gupta established Lupin in 1968, which is today one of India’s leading pharmaceutical companies. In Pune, Maharashtra, Lupin has a state-of the-art research and development unit. It is one of the fastest growing companies as far as oncology, cardiology, gastroenterology, central nervous system, anti-infective, anti-asthma and diabetology therapies are concerned. Lupin’s market capitalisation amounted to Rs. 77,115.19 crore on 15 June 2015.
Dr. Reddy’s Labs
Based in Hyderabad, Telangana, Dr. Reddy’s Laboratories is a multinational pharmaceutical entity. It was founded in 1984 as a manufacturer of APIs. A vast range of pharmaceutical products are offered by Dr. Reddy’s Labs. It has 60 APIs and 190 medications to treat various kinds of ailments. It is now India’s third largest pharmaceutical company in terms of market capitalisation, which was valued at Rs. 56,638.13 crore on 15 June 2015.
Dr. K. A. Hamied set up Cipla Limited in 1935, which is one of the biggest biotechnology and pharmaceutical multinational companies of India today. APIs and formulations are produced at 34 state-of the-art Cipla plants spread across the country. Primarily, medicines for treatments of ailments like depression, obesity, cardiovascular diseases, arthritis and diabetes are developed by Cipla. It is India’s fourth largest pharmaceutical company accounting for a market capitalisation worth Rs. 47,025.38 crore on 15 June 2015.
Aurobindo Pharma was founded by K. Nityananda Reddy and P.V. Ramaprasad Reddy with others in 1986. Headquartered in Hyderabad, Telangana, Aurobindo Pharma Limited manufactures APIs and generic pharmaceuticals. Six prime therapeutic areas of medication addressed by the company are anti-allergic, gastroenterology, antiretrovirals, antibiotics, central nervous system and cardiology. With the market capitalisation valued at Rs. 37,281.76 crore on 15 June 2015, Aurobindo Pharma Limited is India’s fifth largest pharmaceutical company.
The city of Ahmedabad in the western Indian state of Gujarat is home to the head office of Cadila Healthcare that was founded in 1952. The company has around 20 different manufacturing locations across the country. Cadila Healthcare is India’s sixth largest pharmaceutical company in terms of market capitalisation that amounted to Rs. 36,159.61 crore on 15 June 2015.
One of the oldest and most experienced players in the pharmaceutical industry of India, GlaxoSmithKline Pharmaceuticals Limited was established in 1924. GlaxoSmithKline Pharmaceuticals is one of the world’s top research-based health management and pharmaceutical companies. Major therapeutic areas of medication addressed by the company are anti-infectives, dermatology, oncology, gynaecology, diabetes, cardiology and respiratory products. In addition to that, it provides vaccines for cervical cancer, hepatitis B, hepatitis A, rota-virus, influenza, tetanus, chickenpox, pertussis and diphtheria amongst many. The market capitalisation of GlaxoSmithKline Pharmaceuticals Limited stood at Rs. 27,522.55 crore on 15 June 2015.
Glenmark Pharmaceuticals is an Indian pharmaceutical company founded in 1977 and headquartered in Mumbai, Maharashtra. It specialises in developing and marketing APIs and formulations and covers segments such as diabetology, dermatology, ENT, internal medicine, gynaecology and paediatrics. Glenmark Pharmaceuticals is India’s eighth largest pharmaceutical entity by market capitalisation, which was valued at Rs. 25,045.36 crore on 15 June 2015.